ArticleObservational studies2025
Commentary on ``Nonparametric identification is not enough, but randomized controlled trials are'': Statistical considerations for generating reliable evidence across a spectrum of studies that increasingly involve real-world elements.
Article in Observational studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Considerations for the Integration of Clinical Trials and Real-World Data.Clinical pharmacology and therapeutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Judea Pearl, quoted in Pearl and Mackenzie (2008), stated that "once we have understood why [randomized controlled trials] RCTs work, there is no need to put them on a pedestal and treat them as the gold standard of causal analysis, which all other methods should emulate." In Aronow et al. (2024), this claim is refuted, drawing on results of Robins and Ritov (1997). The argument is made that statistical estimation and inference tend to be fundamentally more difficult in observational studies than in randomized controlled trials, even when all confounders are observed and measured without error. We congratulate the authors for raising this highly timely, interesting discussion and welcome this opportunity to join this important debate. In this commentary, we focus on what it takes to generate reliable evidence across a spectrum of studies that increasingly involve real-world elements and less control over design. A related question is whether, along this spectrum of studies, the reliability of evidence generated by a statistical analysis decreases. We claim that this is not the case, but that the challenge for the appropriate statistical method increases, requiring sophisticated and careful execution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.